Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine☆
To access this article, please choose from the options below
☆ Conflict of interest statement: C.E.M.G. is a consultant to and has received research funding, travel grants, and lecture fees from Novartis.
PII: S0738-081X(07)00266-0
doi:10.1016/j.clindermatol.2007.11.006
Crown Copyright © 2008. Published by Elsevier Inc. All rights reserved.
